{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T22:09:27Z","timestamp":1775254167590,"version":"3.50.1"},"reference-count":37,"publisher":"MDPI AG","issue":"21","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background and Objectives: Malan syndrome is a rare overgrowth syndrome resulting from NFIX haploinsufficiency due to heterozygous loss-of-function mutations or microdeletions of NFIX on chromosome 19 at p13.2. Phenotypic presentation can vary but is characterized by macrocephaly, long and slender body habitus, skeletal abnormalities, and intellectual disability. Methods: Here, we report on the presentation, management, and development of a patient with Malan syndrome, highlighting the clinical and behavioral aspects of this syndrome, therapeutic interventions employed, and the course of disease over a 15-year period. We review medical records, cytogenetic analysis and neuropsychologic testing results, as well as speech pathology, optometric, and medical reports. In addition, we discuss personalized therapeutic strategies that could potentially be exploited in the future for such overgrowth syndromes. Results: To our knowledge, this is the first longitudinal follow-up report of a case of Malan syndrome to highlight the clinical course, interventions employed, and resulting improvements in neurocognitive function over time. Conclusions: This case highlights the importance of early diagnosis, intervention, and preventative care in overgrowth syndromes, as well as the potential for therapeutic intervention in the future.<\/jats:p>","DOI":"10.3390\/jcm13216575","type":"journal-article","created":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T11:53:43Z","timestamp":1730462023000},"page":"6575","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["A Patient Case of Malan Syndrome Involving 19p13.2 Deletion of NFIX with Longitudinal Follow-Up and Future Prospectives"],"prefix":"10.3390","volume":"13","author":[{"given":"Simran","family":"Makker","sequence":"first","affiliation":[{"name":"Laurel Springs School, Ojai, CA 93023, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernadine R.","family":"Gagnon","sequence":"additional","affiliation":[{"name":"Edward D. Mysak Clinic for Communication Disorders, Teachers College, Columbia University, New York, NY 10027, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1674-0740","authenticated-orcid":false,"given":"Isabella","family":"Trew","sequence":"additional","affiliation":[{"name":"Centre for Molecular Medicine and Innovative Therapeutics, Health Futures Institute, Murdoch University, Murdoch, WA 6150, Australia"},{"name":"Perron Institute for Neurological and Translational Science, Nedlands, WA 6009, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivian","family":"Mougios","sequence":"additional","affiliation":[{"name":"Action Potential Institute, 145 W 96th S, New York, NY 10025, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Hanna","sequence":"additional","affiliation":[{"name":"Gold Coast Optometric Vision Performance, Oyster Bay, NY 11771, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7218-3027","authenticated-orcid":false,"given":"Jessica M.","family":"Cale","sequence":"additional","affiliation":[{"name":"Centre for Molecular Medicine and Innovative Therapeutics, Health Futures Institute, Murdoch University, Murdoch, WA 6150, Australia"},{"name":"Perron Institute for Neurological and Translational Science, Nedlands, WA 6009, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7188-5035","authenticated-orcid":false,"given":"Craig S.","family":"McIntosh","sequence":"additional","affiliation":[{"name":"Centre for Molecular Medicine and Innovative Therapeutics, Health Futures Institute, Murdoch University, Murdoch, WA 6150, Australia"},{"name":"Perron Institute for Neurological and Translational Science, Nedlands, WA 6009, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,11,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/ajmg.c.30060","article-title":"Clinical and molecular overlap in overgrowth syndromes","volume":"137","author":"Baujat","year":"2005","journal-title":"Am. J. Med. Genet. C Semin. Med. Genet."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13039-016-0282-4","article-title":"19p13.2 Microdeletion including NFIX associated with overgrowth and intellectual disability suggestive of Malan syndrome","volume":"9","author":"Dong","year":"2016","journal-title":"Mol. Cytogenet."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"3855","DOI":"10.1128\/MCB.02293-06","article-title":"Nuclear factor I X deficiency causes brain malformation and severe skeletal defects","volume":"27","author":"Driller","year":"2007","journal-title":"Mol. Cell Biol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"9117","DOI":"10.1093\/nar\/14.22.9117","article-title":"Analysis of nuclear factor I binding to DNA using degenerate oligonucleotides","volume":"14","author":"Gronostajski","year":"1986","journal-title":"Nucleic Acids Res."},{"key":"ref_5","first-page":"964","article-title":"Site-specific DNA binding of nuclear factor I: Analyses of cellular binding sites","volume":"5","author":"Gronostajski","year":"1985","journal-title":"Mol. Cell Biol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/0014-5793(94)00585-0","article-title":"Transcription factor nuclear factor I proteins form stable homo-and heterodimers","volume":"348","author":"Kruse","year":"1994","journal-title":"FEBS Lett."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.tcb.2018.09.003","article-title":"Nuclear Factor One X in Development and Disease","volume":"29","author":"Piper","year":"2019","journal-title":"Trends Cell Biol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Campbell, C.E., Piper, M., Plachez, C., Yeh, Y.T., Baizer, J.S., Osinski, J.M., Litwack, E.D., Richards, L.J., and Gronostajski, R.M. (2008). The transcription factor Nfix is essential for normal brain development. BMC Dev. Biol., 8.","DOI":"10.1186\/1471-213X-8-52"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/cercor\/bhs307","article-title":"NFIX regulates neural progenitor cell differentiation during hippocampal morphogenesis","volume":"24","author":"Heng","year":"2014","journal-title":"Cereb. Cortex"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.cell.2014.04.006","article-title":"Reprogramming committed murine blood cells to induced hematopoietic stem cells with defined factors","volume":"157","author":"Riddell","year":"2014","journal-title":"Cell"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ydbio.2017.10.019","article-title":"Transcriptional regulation of Nfix by NFIB drives astrocytic maturation within the developing spinal cord","volume":"432","author":"Matuzelski","year":"2017","journal-title":"Dev. Biol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/(SICI)1097-0177(199703)208:3<313::AID-AJA3>3.0.CO;2-L","article-title":"Expression patterns of the four nuclear factor I genes during mouse embryogenesis indicate a potential role in development","volume":"208","author":"Chaudhry","year":"1997","journal-title":"Dev. Dyn."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3532","DOI":"10.1002\/cne.22721","article-title":"Nuclear factor one X regulates the development of multiple cellular populations in the postnatal cerebellum","volume":"519","author":"Piper","year":"2011","journal-title":"J. Comp. Neurol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.ydbio.2007.01.016","article-title":"Intrinsic phenotypic diversity of embryonic and fetal myoblasts is revealed by genome-wide gene expression analysis on purified cells","volume":"304","author":"Biressi","year":"2007","journal-title":"Dev. Biol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Keeshan, K., O\u2019Connor, C., Campos, J., Murphy, B., Hannon, M., and Michie, A. (2015). Nfix expression critically modulates early B lymphopoiesis and myelopoiesis. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0120102"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1016\/j.celrep.2016.02.014","article-title":"Nfix Regulates Temporal Progression of Muscle Regeneration through Modulation of Myostatin Expression","volume":"14","author":"Rossi","year":"2016","journal-title":"Cell Rep."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"29306","DOI":"10.18632\/oncotarget.8720","article-title":"Nuclear factor one B (NFIB) encodes a subtype-specific tumour suppressor in glioblastoma","volume":"7","author":"Stringer","year":"2016","journal-title":"Oncotarget"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/s13023-022-02384-9","article-title":"A deep phenotyping experience: Up to date in management and diagnosis of Malan syndrome in a single center surveillance report","volume":"17","author":"Macchiaiolo","year":"2022","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ajhg.2010.07.001","article-title":"Distinct effects of allelic NFIX mutations on nonsense-mediated mRNA decay engender either a Sotos-like or a Marshall-Smith syndrome","volume":"87","author":"Malan","year":"2010","journal-title":"Am. J. Hum. Genet."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/GIM.0b013e3181e59291","article-title":"A novel microdeletion\/microduplication syndrome of 19p13.13","volume":"12","author":"Dolan","year":"2010","journal-title":"Genet. Med."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Robinson, J.T., Thorvaldsdottir, H., Turner, D., and Mesirov, J.P. (2023). igv.js: An embeddable JavaScript implementation of the Integrative Genomics Viewer (IGV). Bioinformatics, 39.","DOI":"10.1093\/bioinformatics\/btac830"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/ejhg.2014.162","article-title":"Malan syndrome: Sotos-like overgrowth with de novo NFIX sequence variants and deletions in six new patients and a review of the literature","volume":"23","author":"Klaassens","year":"2015","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/ajmg.c.31359","article-title":"The NSD1 and EZH2 overgrowth genes, similarities and differences","volume":"163","author":"Rahman","year":"2013","journal-title":"Am. J. Med. Genet. C Semin. Med. Genet."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Alfieri, P., Macchiaiolo, M., Collotta, M., Montanaro, F.A.M., Caciolo, C., Cumbo, F., Galassi, P., Panfili, F.M., Cortellessa, F., and Zollino, M. (2022). Characterization of Cognitive, Language and Adaptive Profiles of Children and Adolescents with Malan Syndrome. J. Clin. Med., 11.","DOI":"10.3390\/jcm11144078"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e997","DOI":"10.1002\/mgg3.997","article-title":"Malan syndrome in a patient with 19p13.2p13.12 deletion encompassing NFIX and CACNA1A genes: Case report and review of the literature","volume":"7","author":"Bellucco","year":"2019","journal-title":"Mol. Genet. Genom. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.ejmg.2015.06.009","article-title":"NFIX mutations affecting the DNA-binding domain cause a peculiar overgrowth syndrome (Malan syndrome): A new patients series","volume":"58","author":"Gurrieri","year":"2015","journal-title":"Eur. J. Med. Genet."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/MCD.0000000000000185","article-title":"Two patients with 19p13.2 deletion (Malan syndrome) involving NFIX and CACNA1A with overgrowth, developmental delay, and epilepsy","volume":"26","author":"Kuroda","year":"2017","journal-title":"Clin. Dysmorphol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/jir.12787","article-title":"Development, behaviour and sensory processing in Marshall-Smith syndrome and Malan syndrome: Phenotype comparison in two related syndromes","volume":"64","author":"Mulder","year":"2020","journal-title":"J. Intellect. Disabil. Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1002\/humu.23563","article-title":"Further delineation of Malan syndrome","volume":"39","author":"Priolo","year":"2018","journal-title":"Hum. Mutat."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/jhg.2012.7","article-title":"Missense mutations in the DNA-binding\/dimerization domain of NFIX cause Sotos-like features","volume":"57","author":"Yoneda","year":"2012","journal-title":"J. Hum. Genet."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"161","DOI":"10.5507\/bp.2016.006","article-title":"Malan syndrome (Sotos syndrome 2) in two patients with 19p13.2 deletion encompassing NFIX gene and novel NFIX sequence variant","volume":"160","author":"Kucharczyk","year":"2016","journal-title":"Biomed. Pap. Med. Fac. Univ. Palacky. Olomouc Czech Repub."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/s41573-021-00162-z","article-title":"Antisense technology: An overview and prospectus","volume":"20","author":"Crooke","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Crooke, S.T., Liang, X.H., Baker, B.F., and Crooke, R.M. (2021). Antisense technology: A review. J. Biol. Chem., 296.","DOI":"10.1016\/j.jbc.2021.100416"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/978-981-10-4310-9_9","article-title":"Specific Increase of Protein Levels by Enhancing Translation Using Antisense Oligonucleotides Targeting Upstream Open Frames","volume":"983","author":"Liang","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nbt.3589","article-title":"Translation efficiency of mRNAs is increased by antisense oligonucleotides targeting upstream open reading frames","volume":"34","author":"Liang","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.omtm.2017.11.007","article-title":"Emerging Issues in AAV-Mediated In Vivo Gene Therapy","volume":"8","author":"Colella","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1186\/s13023-023-02891-3","article-title":"Parental perspectives of episodic irritability in an ultra-rare genetic disorder associated with NACC1","volume":"18","author":"Schoch","year":"2023","journal-title":"Orphanet J. Rare Dis."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/21\/6575\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:26:33Z","timestamp":1760113593000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/21\/6575"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,1]]},"references-count":37,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2024,11]]}},"alternative-id":["jcm13216575"],"URL":"https:\/\/doi.org\/10.3390\/jcm13216575","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,1]]}}}